— Know what they know.
Not Investment Advice

OMER NASDAQ

Omeros Corporation
1W: -9.9% 1M: -10.6% 3M: -0.7% YTD: -27.0% 1Y: +263.5% 3Y: +124.8% 5Y: -34.3%
$11.46
-0.50 (-4.18%)
 
Weekly Expected Move ±8.0%
$10 $11 $12 $13 $14
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 35 · $829.4M mcap · 70M float · 1.68% daily turnover · Short 64% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.0 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 155.8%
Cost Advantage ★
51
Intangibles
37
Switching Cost
44
Network Effect
43
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. OMER shows a Weak competitive edge (41.0/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 155.8% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$23
Avg Target
$23
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 1Buy: 10Hold: 6Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$23.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-01-08 H.C. Wainwright Brandon Folkes $20 $40 +20 +183.9% $14.09
2025-10-15 H.C. Wainwright $9 $20 +11 +92.7% $10.38
2025-06-27 H.C. Wainwright Brandon Folkes Initiated $9 +181.2% $3.20
2022-12-08 UBS Initiated $2 -1.2% $2.02

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
1
ROE
1
ROA
5
D/E
1
P/E
3
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. OMER receives an overall rating of C+. Strongest factors: ROA (5/5). Areas of concern: DCF (1/5), ROE (1/5), D/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-13 C- C+
2026-05-11 D+ C-
2026-04-01 C- D+
2026-03-31 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

19 Grade D
Profitability
60
Balance Sheet
35
Earnings Quality
0
Growth
Value
61
Momentum
Safety
0
Cash Flow
18
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. OMER scores highest in Value (61/100) and lowest in Earnings Quality (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.60
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
Ohlson O-Score
-2.07
Bankruptcy prob: 11.2%
Moderate
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
25/100
OCF/NI: -1.10x
Accruals: 65.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. OMER scores -4.60, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. OMER scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. OMER's implied 11.2% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. OMER receives an estimated rating of B- (score: 20.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). OMER's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
9.56x
PEG
0.00x
P/S
83.84x
P/B
-13.01x
P/FCF
-7.08x
P/OCF
EV/EBITDA
-8.40x
EV/Revenue
79.61x
EV/EBIT
-8.17x
EV/FCF
-8.31x
Earnings Yield
12.85%
FCF Yield
-14.13%
Shareholder Yield
0.62%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 9.6x earnings, OMER trades at a deep value multiple. An earnings yield of 12.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.128
NI / EBT
×
Interest Burden
-0.792
EBT / EBIT
×
EBIT Margin
-9.746
EBIT / Rev
×
Asset Turnover
0.036
Rev / Assets
×
Equity Multiplier
-1.517
Assets / Equity
=
ROE
-47.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. OMER's ROE of -47.2% is driven by Asset Turnover (0.036), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.13 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
22.19%
Fair P/E
52.88x
Intrinsic Value
$71.75
Price/Value
0.15x
Margin of Safety
85.28%
Premium
-85.28%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with OMER's realized 22.2% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $71.75, OMER appears undervalued with a 85% margin of safety. The adjusted fair P/E of 52.9x compares to the current market P/E of 9.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$11.46
Median 1Y
$6.12
5th Pctile
$1.07
95th Pctile
$35.08
Ann. Volatility
107.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Gregory A. Demopulos,
M.D. President, Chief Executive Officer and Chairman of the Board
$972,525 $— $4,178,008
Peter B. Cancelmo,
J.D. Vice President, General Counsel and Secretary
$489,480 $— $920,702
David J. Borges
Vice President, Finance, Chief Accounting Officer and Treasurer
$325,600 $— $686,274

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
175
-13.4% YoY
Revenue / Employee
Profit / Employee
SGA / Employee
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 1.2% 1.1% -4.0% -4.0% -4.0% -4.1% 86.6% 85.4% 73.6% 36.5% -3.9% -4.0% -4.6% -4.4% 1.5% 1.5% 1.2% 1.2% 1.8% -47.2% -47.19%
ROA -87.7% -77.8% 64.7% 65.4% 64.7% 66.4% 9.4% 9.3% 8.0% 4.0% -24.3% -25.0% -28.9% -27.8% -47.9% -46.7% -37.4% -37.0% -1.2% 31.1% 31.10%
ROIC -9.0% -9.9% -85.3% -81.5% -78.5% -82.6% -55.4% -55.7% -56.8% -56.0% -78.9% -80.5% -89.2% -83.1% 2.0% 2.0% 1.7% 1.6% 1.5% 1.6% 1.56%
ROCE -1.1% -1.1% -62.5% -59.7% -57.4% -60.2% -35.0% -34.4% -34.3% -33.0% -44.3% -45.5% -51.5% -48.3% -80.0% -79.1% -67.2% -59.3% -57.2% -48.8% -48.81%
Gross Margin 98.8% 91.7% 91.65%
Operating Margin 1.3% -1.8% -1.76%
Net Margin -3.5% 5.7% 5.67%
EBITDA Margin 1.3% -1.7% -1.74%
FCF Margin -3.3% -10.4% 1.4% 1.1% 96.2% 99.5% -9.6% -9.58%
OCF Margin -3.3% -10.3% 1.4% 1.1% 95.8% 99.3% -9.6% -9.58%
ROA 3Y Avg snapshot only -18.74%
ROIC Economic snapshot only -4.23%
Cash ROA snapshot only -34.20%
NOPAT Margin snapshot only -10.35%
Pretax Margin snapshot only 7.72%
R&D / Revenue snapshot only 7.13%
SGA / Revenue snapshot only 3.38%
SBC / Revenue snapshot only 58.01%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -6.64 -6.97 2.07 1.92 0.89 0.99 2.99 6.25 8.49 9.18 -1.73 -1.67 -1.68 -1.71 -3.67 -3.12 -1.44 -2.24 -325.70 7.78 9.564
P/S Ratio 25.19 81.08 -5.03 -4.72 -2.16 -2.47 67.79 83.839
P/B Ratio -7.67 -7.14 16.91 15.85 7.25 8.31 1.66 3.41 3.99 2.14 -8.17 -8.12 -9.42 -9.21 -3.15 -2.61 -0.96 -1.49 -5.98 -3.67 -13.013
P/FCF -7.63 -7.83 -3.66 -4.44 -2.25 -2.49 -1.64 2.83 3.79 2.19 2.75 -1.43 -1.51 -1.49 -3.86 -3.34 -1.48 -2.58 -9.39 -7.08 -7.076
P/OCF 2.83 3.78 2.18 2.73
EV/EBITDA -6.56 -6.17 -2.60 -2.60 -1.73 -1.76 -1.82 -2.82 -3.15 -2.22 -2.75 -2.67 -2.55 -2.69 -4.41 -3.83 -2.22 -3.40 -10.96 -8.40 -8.399
EV/Revenue 28.83 93.67 -7.42 -7.10 -4.54 -4.86 79.61 79.607
EV/EBIT -6.50 -6.11 -2.58 -2.59 -1.72 -1.75 -1.81 -2.81 -3.13 -2.20 -2.73 -2.65 -2.54 -2.68 -4.38 -3.80 -2.21 -3.32 -10.70 -8.17 -8.168
EV/FCF -8.73 -9.04 -5.39 -6.68 -4.73 -4.88 -3.34 4.26 5.43 3.94 5.30 -2.76 -2.73 -2.71 -4.64 -4.15 -2.46 -3.69 -10.40 -8.31 -8.309
Earnings Yield -15.1% -14.3% 48.3% 52.1% 1.1% 1.0% 33.4% 16.0% 11.8% 10.9% -57.7% -59.8% -59.5% -58.5% -27.3% -32.1% -69.7% -44.6% -0.3% 12.8% 12.85%
FCF Yield -13.1% -12.8% -27.3% -22.5% -44.5% -40.2% -61.1% 35.3% 26.4% 45.7% 36.4% -70.0% -66.1% -67.3% -25.9% -30.0% -67.6% -38.8% -10.6% -14.1% -14.13%
PEG Ratio snapshot only 0.002
Shareholder Yield snapshot only 0.62%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 4.12 4.12 4.79 4.79 4.79 4.79 3.25 3.25 3.25 3.25 4.09 4.09 4.09 4.09 1.69 1.69 1.69 1.69 1.69 1.69 1.686
Quick Ratio 4.08 4.08 4.79 4.79 4.79 4.79 3.25 3.25 3.25 3.25 4.09 4.09 4.09 4.09 1.69 1.69 1.69 1.69 1.69 1.69 1.686
Debt/Equity -2.23 -2.23 14.63 14.63 14.63 14.63 3.99 3.99 3.99 3.99 -14.47 -14.47 -14.47 -14.47 -1.13 -1.13 -1.13 -1.13 -1.13 -1.13 -1.134
Net Debt/Equity 8.01 8.01 8.01 8.01 1.72 1.72 1.72 1.72
Debt/Assets 1.48 1.48 0.83 0.83 0.83 0.83 0.58 0.58 0.58 0.58 0.96 0.96 0.96 0.96 0.75 0.75 0.75 0.75 0.75 0.75 0.747
Debt/EBITDA -1.67 -1.66 -1.52 -1.59 -1.66 -1.58 -2.16 -2.20 -2.20 -2.29 -2.53 -2.46 -2.17 -2.32 -1.32 -1.33 -1.57 -1.81 -1.88 -2.21 -2.208
Net Debt/EBITDA -0.83 -0.83 -0.83 -0.87 -0.91 -0.87 -0.93 -0.95 -0.95 -0.99 -1.33 -1.29 -1.14 -1.22 -0.74 -0.75 -0.89 -1.02 -1.06 -1.25 -1.247
Interest Coverage -6.61 -7.18 -11.68 -11.13 -10.69 -11.21 -7.02 -6.09 -5.44 -4.73 -5.26 -5.34 -5.78 -6.24 -6.40 -7.77 -12.18 -5.80 -6.63 -5.01 -5.005
Equity Multiplier -1.50 -1.50 17.63 17.63 17.63 17.63 6.90 6.90 6.90 6.90 -15.14 -15.14 -15.14 -15.14 -1.52 -1.52 -1.52 -1.52 -1.52 -1.52 -1.517
Cash Ratio snapshot only 1.133
Debt Service Coverage snapshot only -4.867
Cash to Debt snapshot only 0.435
FCF to Debt snapshot only -0.458
Defensive Interval snapshot only 445.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.23 0.07 -0.27 -0.27 -0.27 -0.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.036
Inventory Turnover 1.02 0.94 0.22 -0.35 -0.94 -1.38
Receivables Turnover (trade) 1.89 0.55 -4.07 -4.07 -4.07 -4.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.43 1.426
Payables Turnover 0.27 0.25 0.02 -0.03 -0.07 -0.11 0.00 0.00 0.00 0.00 0.03 0.06 0.06 0.06 0.07 0.04 1.56 1.56 1.74 1.88 1.883
DSO (trade) 193 667 -90 -90 -90 -90 256 256.0 days
DIO 357 388 1627 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 1360 1477 21130 12197 6114 6114 6114 4921 8256 235 235 209 194 193.8 days
Cash Conversion Cycle (trade) -810 -422 62 62.2 days
Fixed Asset Turnover snapshot only 0.561
Cash Velocity snapshot only 0.110
Capital Intensity snapshot only 28.008
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -63.4% -89.0% -2.1% -2.6% -3.2% -8.5% 1.0% 1.0% 1.0% 1.0%
Net Income -29.1% 4.9% 2.4% 2.4% 2.4% 2.6% -75.6% -76.2% -79.2% -90.0% -3.5% -3.6% -4.5% -7.7% -33.1% -26.2% 12.5% 9.9% 97.9% 1.6% 1.56%
EPS -12.8% 11.4% 2.4% 2.3% 2.4% 2.6% -75.7% -76.2% -79.3% -90.0% -3.5% -3.8% -4.8% -8.3% -42.9% -27.8% 13.5% 21.2% 98.0% 1.5% 1.51%
FCF -56.5% -4.9% -9.6% 35.4% 36.7% 27.8% 21.3% 2.2% 2.2% 2.1% 1.9% -2.4% -2.7% -2.8% -3.0% -0.7% 23.6% 32.0% 22.0% 33.7% 33.72%
EBITDA -94.9% -44.8% -87.6% -52.0% -30.0% -36.4% 30.6% 28.6% 26.1% 32.3% 9.6% 5.6% -7.5% -4.6% -9.7% -5.6% 21.0% 26.6% 29.8% 39.6% 39.59%
Op. Income -74.3% -63.7% -1.1% -67.3% -41.9% -36.1% 29.4% 25.8% 21.4% 26.4% -0.7% -2.3% -11.1% -5.1% -2.9% 1.6% 25.6% 25.4% 27.5% 36.3% 36.29%
OCF Growth snapshot only 33.67%
Asset Growth snapshot only 0.00%
Debt Growth snapshot only 0.00%
Shares Change snapshot only 9.39%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -1.7% -21.1%
Revenue 5Y 6.1% -21.4% -27.8% -27.76%
EPS 3Y 22.2% 22.19%
EPS 5Y
Net Income 3Y 22.6% 22.63%
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y -2.0% -23.1%
Gross Profit 5Y 6.4% -22.6%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 15.9% 15.9% 63.5% 63.5% 63.5% 63.5% 62.8% 62.8% 62.8% 62.8% 27.8% 27.8% 27.8% 27.8% -12.9% -12.9% -12.9% -12.9% -22.3% -22.3% -22.31%
Assets 5Y 29.9% 29.9% 44.2% 44.2% 44.2% 44.2% 38.4% 38.4% 38.4% 38.4% 31.6% 31.6% 31.6% 31.6% 15.1% 15.1% 15.1% 15.1% 8.9% 8.9% 8.88%
Equity 3Y -66.8% -66.8% -66.8% -66.8%
Book Value 3Y -69.4% -69.4% -69.4% -69.4%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.21 0.02 0.14 0.23 0.36 0.48 0.37 0.35 0.30 0.23 0.13 0.23 0.34 0.39 0.22 0.23 0.19 0.18 0.66 0.50 0.503
Earnings Stability 0.88 0.59 0.23 0.22 0.24 0.27 0.35 0.37 0.39 0.40 0.10 0.09 0.06 0.04 0.03 0.02 0.01 0.00 0.05 0.00 0.001
Margin Stability 0.98 0.96 0.99 0.99 0.99 0.95 1.00 0.99 0.99 0.95
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.88 0.98 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.20 0.200
Earnings Smoothness 0.00 0.00 0.00 0.00
ROE Trend
Gross Margin Trend -0.03 -0.10
FCF Margin Trend -2.31 -9.50
Sustainable Growth Rate 86.6% 85.4% 73.6% 36.5%
Internal Growth Rate 1.8% 1.9% 1.8% 2.0% 10.4% 10.2% 8.7% 4.1% 45.1% 45.14%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.87 0.89 -0.56 -0.43 -0.39 -0.40 -1.82 2.21 2.24 4.21 -0.63 1.17 1.11 1.15 0.95 0.93 0.97 0.87 34.65 -1.10 -1.100
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only -1.100
CapEx/Revenue 0.5% 1.9% -0.3% -0.3% -0.4% -0.2% 0.2% 0.24%
CapEx/Depreciation snapshot only 0.009
Accruals Ratio -0.11 -0.09 1.01 0.94 0.90 0.93 0.27 -0.11 -0.10 -0.13 -0.40 0.04 0.03 0.04 -0.02 -0.03 -0.01 -0.05 0.41 0.65 0.653
Sloan Accruals snapshot only -0.010
Cash Flow Adequacy snapshot only -3948.292
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.8% 4.82%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.3% 8.1% 7.0% 7.2% 2.1% 0.0% 0.0% 0.0% 0.0% 0.6% 0.62%
Net Buyback Yield -11.0% -0.7% -1.6% -0.1% -0.2% -0.2% -0.3% -0.0% -0.0% -0.0% 2.3% 8.1% 7.0% 7.2% 2.1% -0.0% -3.6% -13.1% -4.3% -7.6% -7.57%
Total Shareholder Return -11.0% -0.7% -1.6% -0.1% -0.2% -0.2% -0.3% -0.0% -0.0% -0.0% 2.3% 8.1% 7.0% 7.2% 2.1% -0.0% -3.6% -13.1% -4.3% -7.6% -7.57%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.74 0.67 -0.78 -0.82 -0.84 -0.83 -0.26 -0.26 -0.22 -0.11 0.67 0.68 0.70 0.73 0.86 0.87 0.89 0.93 0.27 1.13 1.128
Interest Burden (EBT/EBIT) 1.15 1.14 1.09 1.09 1.09 1.09 1.14 1.16 1.18 1.21 1.21 1.21 1.19 1.18 1.16 1.13 1.03 1.12 0.11 -0.79 -0.792
EBIT Margin -4.44 -15.33 2.88 2.75 2.64 2.77 -9.75 -9.746
Asset Turnover 0.23 0.07 -0.27 -0.27 -0.27 -0.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.036
Equity Multiplier -1.38 -1.38 -6.19 -6.19 -6.19 -6.19 9.23 9.23 9.23 9.23 15.97 15.97 15.97 15.97 -3.16 -3.16 -3.16 -3.16 -1.52 -1.52 -1.517
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.24 $-1.98 $3.11 $3.13 $3.09 $3.18 $0.76 $0.74 $0.64 $0.32 $-1.89 $-2.06 $-2.42 $-2.32 $-2.70 $-2.64 $-2.09 $-1.83 $-0.05 $1.36 $1.36
Book Value/Share $-1.94 $-1.93 $0.38 $0.38 $0.38 $0.38 $1.37 $1.36 $1.36 $1.36 $-0.40 $-0.42 $-0.43 $-0.43 $-3.14 $-3.15 $-3.12 $-2.76 $-2.88 $-2.88 $-0.88
Tangible Book/Share $-1.94 $-1.93 $0.38 $0.38 $0.38 $0.38 $1.37 $1.36 $1.36 $1.36 $-0.40 $-0.42 $-0.43 $-0.43 $-3.14 $-3.15 $-3.12 $-2.76 $-2.88 $-2.88 $-2.88
Revenue/Share $0.59 $0.17 $-1.28 $-1.27 $-1.27 $-1.27 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.16 $0.14
FCF/Share $-1.95 $-1.76 $-1.76 $-1.35 $-1.22 $-1.27 $-1.38 $1.64 $1.43 $1.33 $1.19 $-2.42 $-2.68 $-2.67 $-2.56 $-2.46 $-2.03 $-1.59 $-1.83 $-1.49 $-1.32
OCF/Share $-1.94 $-1.76 $-1.75 $-1.35 $-1.22 $-1.26 $-1.38 $1.64 $1.44 $1.34 $1.20 $-2.41 $-2.68 $-2.67 $-2.56 $-2.46 $-2.03 $-1.59 $-1.83 $-1.49 $-1.32
Cash/Share $2.16 $2.16 $2.51 $2.51 $2.51 $2.51 $3.11 $3.10 $3.10 $3.10 $2.75 $2.92 $2.97 $2.97 $1.55 $1.55 $1.54 $1.36 $1.42 $1.42 $1.88
EBITDA/Share $-2.59 $-2.58 $-3.65 $-3.48 $-3.34 $-3.51 $-2.52 $-2.48 $-2.47 $-2.37 $-2.29 $-2.50 $-2.88 $-2.69 $-2.70 $-2.67 $-2.25 $-1.73 $-1.74 $-1.48 $-1.48
Debt/Share $4.31 $4.30 $5.56 $5.55 $5.55 $5.55 $5.45 $5.44 $5.44 $5.44 $5.79 $6.15 $6.24 $6.24 $3.56 $3.57 $3.53 $3.12 $3.26 $3.26 $3.26
Net Debt/Share $2.15 $2.14 $3.05 $3.04 $3.04 $3.04 $2.34 $2.34 $2.34 $2.34 $3.04 $3.23 $3.27 $3.27 $2.01 $2.01 $2.00 $1.76 $1.84 $1.84 $1.84
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.601
Altman Z-Prime snapshot only -10.225
Piotroski F-Score 3 4 4 4 4 4 3 5 5 5 4 2 2 2 2 2 1 1 1 3 3
Beneish M-Score
Ohlson O-Score snapshot only -2.066
Net-Net WC snapshot only $-5.13
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 20.00 20.00 21.05 21.38 21.53 21.87 23.70 31.40 30.33 29.78 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 10
Sector Credit Rank snapshot only 10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms